Zacks Research Has Weak Estimate for Haemonetics Q1 Earnings
Haemonetics Co. (NYSE:HAE – Free Report) – Research analysts at Zacks Research lowered their Q1 2026 earnings per share (EPS) estimates for Haemonetics in a research report issued to clients and investors on Wednesday, May 28th. Zacks Research analyst R. Department now anticipates that the medical instruments supplier will earn $1.03 per share for the […]
Haemonetics Co. (NYSE:HAE – Free Report) – Research analysts at Zacks Research lowered their Q1 2026 earnings per share (EPS) estimates for Haemonetics in a research report issued to clients and investors on Wednesday, May 28th. Zacks Research analyst R. Department now anticipates that the medical instruments supplier will earn $1.03 per share for the […]
